FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfilePure Extracts Technologies Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PULL.CN
Pure Extracts Technologies Corp. Stock AnalysisComprehensive stock analysis for Pure Extracts Technologies Corp. (PULL.CN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPULL.CN
PULL.CN
Pure Extracts Technologies Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PULL.CN
  1. Home
  2. Stocks
  3. Pure Extracts Technologies Corp.

Pure Extracts Technologies Corp.

🇨🇦PULL.CN•CNQ

Pure Extracts Technologies Corp.

🇨🇦PULL.CN•CNQ
Market cap
$1.17M

Your view on PULL.CN

Mkt Cap
$1.17M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Pure Extracts Technologies Corp.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Ben Nikolaevsky
Headquarters
CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Ben Nikolaevsky
Headquarters
CA
Description

Pure Extracts Technologies Corp. engages in the extraction and processing of cannabis, hemp, and functional mushrooms to produce oils and various derivative products in Canada. The company offers THC and CBD based extracted oils.

It also engages in the development and commercialization of functional mushroom wellness products and psychedelic medical products. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. is headquartered in Pemberton, Canada.

FRC Research

Past Reports

Historical coverage archive.

*Pure Extracts Technologies Corp. had paid FRC a fee for research coverage and distribution of reports. This fee creates a potential conflict of interest which readers should consider.

1 report
Mar 26, 2021

Extracts Company Positioned for Cannabis 2.0 and Mushrooms – Initiating Coverage

PDF
Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Pure Extracts Technologies Corp.. Starting points for Pure Extracts Technologies Corp.: EPS -C$0.05, beta 2.12 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Pure Extracts Technologies Corp.. Pure Extracts Technologies Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Pure Extracts Technologies Corp.. Trailing twelve-month EPS for Pure Extracts Technologies Corp. stands at -C$0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Pure Extracts Technologies Corp.. Pure Extracts Technologies Corp. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold PULL.CN12 companies
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
VLS.AXVita Life Sciences LimitedHealthcareASX—
VM.VVoyageur Pharmaceuticals Ltd.HealthcareTSXV$23.1M
VPHIFValeo Pharma Inc.HealthcareOTC$9,866
VREOFVireo Growth Inc.HealthcareOTC$502.5M
VRNOVerano Holdings Corp.HealthcareOTC$426.9M
VRNO.NEVerano Holdings Corp.HealthcareNEO—
VRTHFIndigenous Bloom Hemp Corp.HealthcareOTC$131,146
VTRSViatris Inc.HealthcareNASDAQ$23.3B
VYYRFVoyageur Pharmaceuticals Ltd.HealthcareOTC$22.5M
WEED.TOCanopy Growth CorporationHealthcareTSX$323.7M
WIBFFWest Island Brands Inc.HealthcareOTC$60,061
WLDFFWildflower Brands Inc.HealthcareOTC$1,393
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Pure Extracts Technologies Corp.. Coverage tracks Pure Extracts Technologies Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Pure Extracts Technologies Corp.

News

Latest Market News